Cytokinetics (CYTK) Change in Account Payables (2016 - 2025)
Historic Change in Account Payables for Cytokinetics (CYTK) over the last 15 years, with Q4 2024 value amounting to $5.9 million.
- Cytokinetics' Change in Account Payables fell 2342.11% to $5.9 million in Q4 2024 from the same period last year, while for Dec 2024 it was -$4.5 million, marking a year-over-year decrease of 2871.09%. This contributed to the annual value of -$4.5 million for FY2024, which is 2871.09% down from last year.
- Per Cytokinetics' latest filing, its Change in Account Payables stood at $5.9 million for Q4 2024, which was down 2342.11% from $1.7 million recorded in Q3 2024.
- Over the past 5 years, Cytokinetics' Change in Account Payables peaked at $13.0 million during Q4 2022, and registered a low of -$10.3 million during Q1 2024.
- In the last 5 years, Cytokinetics' Change in Account Payables had a median value of $406500.0 in 2021 and averaged -$124850.0.
- Data for Cytokinetics' Change in Account Payables shows a peak YoY increase of 90710.9% (in 2022) and a maximum YoY decrease of 63089.38% (in 2022) over the last 5 years.
- Cytokinetics' Change in Account Payables (Quarter) stood at $1.3 million in 2020, then soared by 193.98% to $3.9 million in 2021, then skyrocketed by 238.29% to $13.0 million in 2022, then plummeted by 40.9% to $7.7 million in 2023, then dropped by 23.42% to $5.9 million in 2024.
- Its Change in Account Payables was $5.9 million in Q4 2024, compared to $1.7 million in Q3 2024 and -$1.8 million in Q2 2024.